Personal Cfo Solutions, LLC Eli Lilly & CO Transaction History

Personal Cfo Solutions, LLC

$704 Million
Q3 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 2,740 shares of LLY stock, worth $2.05 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

2,740

Previous 2,755 0.54%

Holding current value

$2.05 Million

Previous $2.49 Million 2.69%

% of portfolio

0.34%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 0.54%	2,740 $2.43 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $229,783 - $288,165	317 Added 13.0%	2,755 $2.49 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $34,347 - $45,952	58 Added 2.44%	2,438 $1.9 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $102,937 - $121,349	-196 Reduced 7.61%	2,380 $1.39 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $231,260 - $318,827	532 Added 26.03%	2,576 $1.38 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $43,842 - $58,622	-125 Reduced 5.76%	2,044 $958,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $20,190 - $23,713	65 Added 3.09%	2,169 $744,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $55,306 - $64,443	-172 Reduced 7.56%	2,104 $769,000
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $16,602 - $18,920	56 Added 2.52%	2,276 $736,000
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $74,699 - $87,708	-268 Reduced 10.77%	2,220 $720,000
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $1,877 - $2,333	8 Added 0.32%	2,488 $712,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $65,656 - $81,479	292 Added 13.35%	2,480 $685,000
Q3 2021 Nov 18, 2021	BUY	$221.6 - $272.71 $19,944 - $24,543	90 Added 4.29%	2,188 $506,000
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $23,832 - $30,827	132 Added 6.71%	2,098 $482,000
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $26,126 - $33,822	-159 Reduced 7.48%	1,966 $367,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $66,012 - $87,350	506 Added 31.25%	2,125 $358,000
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $4,240 - $4,904	-29 Reduced 1.76%	1,619 $0
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $224,820 - $270,568	1,648 New	1,648 $271,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Eli Lilly & CO Transaction History